4//SEC Filing
BRYNJELSEN SEAN 4
Accession 0001493152-22-005605
CIK 0001710340other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 4:27 PM ET
Size
5.3 KB
Accession
0001493152-22-005605
Insider Transaction Report
Form 4
BRYNJELSEN SEAN
DirectorPresident & CEO10% Owner
Transactions
- Award
Stock Option(Right to buy)
2022-02-07+416,500→ 1,601,500 totalExercise: $3.78Exp: 2032-02-07→ Common Stock (416,500 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in 24 equal monthly installments from the date of grant until fully vested and exercisable on February 7, 2024.
Documents
Issuer
Eton Pharmaceuticals, Inc.
CIK 0001710340
Entity typeother
Related Parties
1- filerCIK 0001669976
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 4:27 PM ET
- Size
- 5.3 KB